SequelSEC

MeiraGTx Holdings plc MGTX

Biological Products, (No Diagnostic Substances) · CIK 0001735438 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$81.39M
Fiscal year ended 2025-12-31
Operating income
-$105.97M
Fiscal year ended 2025-12-31
Free cash flow
-$50.18M
Fiscal year ended 2025-12-31

MeiraGTx Holdings plc (MGTX) reported revenue of $81.39M and net income of -$114.20M for the fiscal year ended 2025-12-31. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from MeiraGTx Holdings plc’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Biological Products, (No Diagnostic Substances).

Income

MeiraGTx Holdings plc income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue$81.39M$33.28M$14.02M$15.92M$37.70M$15.56M$13.29M
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$105.97M-$164.21M-$137.06M-$116.36M-$72.76M-$62.55M-$58.27M
Net income-$114.20M-$147.79M-$84.03M-$129.62M-$79.56M-$57.99M-$54.75M
Research & development$129.62M$119.48M$103.78M$85.72M$66.69M$33.91M$24.88M
Weighted-average diluted sharesshares 80.43Mshares 69.82Mshares 56.49Mshares 45.18Mshares 44.14Mshares 37.72MUnavailable
Pretax income-$114.20M-$147.79M-$84.03M-$129.62M-$79.56M-$57.99M-$54.75M
Income tax expense$0$0$0Unavailable$0$0$0
Diluted EPS$-1.42$-2.12$-1.49$-2.87$-1.80$-1.54Unavailable
Selling, general & administrative$57.74M$78.01MUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$52.90M$54.22M$47.29M$46.55M$43.76M$44.21M$46.68M
Selling & marketing$4.84M$23.79MUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

MeiraGTx Holdings plc balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Cash & equivalents$65.93M$103.66M$129.57M$115.52M$137.70M$209.52M$227.23M
Total assets$244.43M$269.75M$326.74M$318.24M$320.16M$363.70M$323.89M
Current assets$91.76M$123.52M$159.62M$154.34M$183.24M$272.58M$268.98M
Total liabilities$250.22M$201.92M$188.57M$200.50M$134.76M$125.14M$133.09M
Current liabilities$122.56M$60.78M$67.08M$82.07M$68.13M$54.15M$49.20M
Total equity incl. NCI-$5.79M$67.83M$138.18M$117.74M$185.40M$238.56M$190.80M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailable$385.00KUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$3.00M$707.00K$10.14M$21.33MUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$10.07M$23.59M$16.04M$16.62M$15.35M$7.13M$3.76M

Cash flow

MeiraGTx Holdings plc cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Operating cash flow-$46.36M-$104.50M-$105.36M-$73.10M-$10.53M-$63.97M$20.04M
Capital expenditures$3.83M$4.96M$20.17M$44.96M$46.35M$20.92M$8.98M
Investing cash flow-$4.11M$23.48M$34.03M-$44.96M-$61.72M-$37.02M-$9.37M
Financing cash flow$12.27M$54.53M$84.02M$95.20M$1.71M$82.73M$148.23M
Net change in cashUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Stock-based compensation$22.10M$25.19M$27.72M$28.62M$20.78M$18.42M$15.93M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$12.54M$12.83M$13.73M$8.72M$7.87M$4.17M$2.24M

Derived

MeiraGTx Holdings plc derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Free cash flow-$50.18M-$109.45M-$125.54M-$118.06M-$56.88M-$84.89M$11.06M
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating margin-130.2%-493.4%-977.8%Unavailable-193.0%-401.9%-438.4%
FCF margin-61.7%-328.9%-895.6%Unavailable-150.9%-545.5%83.2%
SBC / revenue27.2%75.7%197.7%Unavailable55.1%118.3%119.8%
Current ratio0.75x2.03x2.38x1.88x2.69x5.03x5.47x
Revenue YoY growth144.6%137.4%-12.0%-57.8%142.2%17.1%Unavailable
Net margin-140.3%-444.1%-599.5%Unavailable-211.0%-372.6%-411.9%
R&D / revenue159.3%359.0%740.4%Unavailable176.9%217.9%187.1%
CapEx / revenue4.7%14.9%143.9%Unavailable122.9%134.4%67.6%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MGTX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-30View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-13View SEC filing

Companies in the same industry

ABOS ABPO ACOG ADAPY ADMA ADPT AGEN AGTX AIM ALEC ALGS ALLO

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.